Literature DB >> 10887201

Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain.

G Xiao1, S C Sun.   

Abstract

Nuclear factor kappaB (NF-kappaB)-inducing kinase (NIK) participates in the activation of NF-kappaB, a family of eukaryotic transcription factors that mediate cell growth and transformation. NIK activates the IkappaB kinase both in vivo and in vitro, although how the activity of NIK is regulated has remained unclear. Here we show that the N-terminal region of NIK contains a negative-regulatory domain (NRD), which is composed of a basic motif and a proline-rich repeat motif. Deletion of these motifs leads to a marked enhancement of NIK function. We further demonstrate that the N-terminal NRD interacts with the C-terminal region of NIK, thereby inhibiting the binding of NIK to its substrate IkappaB kinase. Consistently, when expressed alone, the NRD potently inhibits NIK-mediated NF-kappaB signaling. These results provide a new insight into the mechanism of NIK regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887201     DOI: 10.1074/jbc.M002552200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha.

Authors:  G Xiao; M E Cvijic; A Fong; E W Harhaj; M T Uhlik; M Waterfield; S C Sun
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

2.  Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters.

Authors:  Guoliang Qing; Zhaoxia Qu; Gutian Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-15       Impact factor: 11.205

3.  Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.

Authors:  Dirk Brenner; Alexander Golks; Friedemann Kiefer; Peter H Krammer; Rüdiger Arnold
Journal:  EMBO J       Date:  2005-12-08       Impact factor: 11.598

Review 4.  NF-κB inducing kinase: a key regulator in the immune system and in cancer.

Authors:  Yee Mon Thu; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-03       Impact factor: 7.638

5.  The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis.

Authors:  Jing Fu; Zhaoxia Qu; Pengrong Yan; Chie Ishikawa; Rami I Aqeilan; Arnold B Rabson; Gutian Xiao
Journal:  Blood       Date:  2010-11-29       Impact factor: 22.113

6.  NFκB-inducing kinase inhibits NFκB activity specifically in neurons of the CNS.

Authors:  Xianrong Mao; Bounleut Phanavanh; Hamdan Hamdan; Andréa M Moerman-Herzog; Steven W Barger
Journal:  J Neurochem       Date:  2016-03-15       Impact factor: 5.372

Review 7.  Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.

Authors:  Kristen P Zeligs; Monica K Neuman; Christina M Annunziata
Journal:  Clin Cancer Res       Date:  2016-07-15       Impact factor: 12.531

8.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

9.  Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway.

Authors:  Ping Liu; Kui Li; Roberto P Garofalo; Allan R Brasier
Journal:  J Biol Chem       Date:  2008-06-12       Impact factor: 5.157

10.  Noncanonical Nuclear Factor Kappa B (NF-κB) Signaling and Potential for Therapeutics in Sepsis.

Authors:  Simone Thair; James A Russell
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.